ArticleInternational journal of molecular sciences2021

The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.

Petra Grbčić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.